CELSENSE INC

Profile

Company Names

CELSENSE INC

Addresses

603 STANWIX STREET, SUITE 390, PITTSBURGH, PA 15222

603 STANWIX STREET, SUITE 348, PITTSBURGH, PA 15222

Phone Numbers

412-263-2870

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$3,175,800.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2018-05-18 
$125,000.00 
$800,000.00 
$675,000.00 
Debt 
7
2016-08-17 
$710,000.00 
$1,000,000.00 
$290,000.00 
Debt 
6
2015-12-01 
$353,000.00 
$353,000.00 
$0.00 
Debt 
5
2014-08-01 
$267,500.00 
$1,000,000.00 
$732,500.00 
Equity 
4
2012-02-17 
$125,000.00 
$1,250,000.00 
$1,125,000.00 
Equity 
3
2010-04-30 
$684,000.00 
$2,000,000.00 
$1,316,000.00 
Equity 
2
2010-03-31 
$150,000.00 
$150,000.00 
$0.00 
Debt 
1
2009-05-22 
$761,300.00 
$2,500,000.00 
$1,738,700.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERIC 
T. 
AHERNS 
DIRECTOR, EXECUTIVE OFFICER
ERIC 
AHRENS 
DIRECTOR
ERIC 
T. 
AHRENS 
DIRECTOR
T. 
RONALD 
CASPER 
EXECUTIVE OFFICER
LOURDES 
CASTELLANOS 
EXECUTIVE OFFICER
LOURDES 
M. 
CASTELLANOS 
EXECUTIVE OFFICER
JEFFREY 
S. 
FRIEDMAN 
DIRECTOR
DANIEL 
GALLAGHER 
DIRECTOR
DANIEL 
P. 
GALLAGHER, JR. 
DIRECTOR
GREGORY 
HEBRANK 
DIRECTOR
GREGORY 
T. 
HEBRANK 
DIRECTOR
RONALD 
B. 
HERBERMAN 
DIRECTOR, EXECUTIVE OFFICER
PAUL 
KORNBLITH 
DIRECTOR
PAUL 
L. 
KORNBLITH 
DIRECTOR
KEVIN 
S. 
MCCLATCHY 
DIRECTOR
CHARLES 
O-HANLON 
EXECUTIVE OFFICER, DIRECTOR
CHARLES 
F. 
O-HANLON, III 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
 
PETZINGER 
DIRECTOR
THOMAS 
 
PETZINGER, JR. 
EXECUTIVE OFFICER, DIRECTOR
GERALD 
L. 
TARANTINO 
DIRECTOR
GERALD 
TARANTINO 
DIRECTOR
L. 
GERALD 
TARANTINO 
DIRECTOR
D. 
LANSING 
TAYLOR 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-18 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-01 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-08-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#